List view / Grid view
The producers of hydroxychloroquine have stated they will donate 130…
The producers of hydroxychloroquine have stated they will donate 130 million doses if the drug is approved as a treatment for the COVID-19 coronavirus.
A Phase I clinical trial to investigate mRNA-1273, a vaccine…
A Phase I clinical trial to investigate mRNA-1273, a vaccine to prevent the spread of the coronavirus COVID-19, has begun in the US.
Using AAV-based technology to deliver mAbs in a Phase I…
Using AAV-based technology to deliver mAbs in a Phase I trial, researchers report that participants successfully developed antibodies against HIV.
The US NIH has initiated a clinical trial for remdesivir…
The US NIH has initiated a clinical trial for remdesivir and two pharmaceutical companies will work together to manufacture antibody treatments to tackle the coronavirus.
The US NIAID has stopped its HVTN 702 clinical trial…
The US NIAID has stopped its HVTN 702 clinical trial for an HIV vaccine after an independent board found that the treatment did not prevent the condition.
The BEAT-MS trial aims to compare the experimental autologous hematopoietic…
The BEAT-MS trial aims to compare the experimental autologous hematopoietic stem cell transplantation (AHSCT) therapy to the best available biologic therapies for multiple sclerosis (MS).
NIAID has released a plan for research in the infectious…
NIAID has released a plan for research in the infectious disease TB in order to strengthen efforts and resolve to attack this disease...
